These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29975020)

  • 21. Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study.
    Rodriguez P; Belcaro G; Dugall M; Hu S; Luzzi R; Ledda A; Ippolito E; Corsi M; Ricci A; Feragalli B; Cornelli U; Gizzi C; Hosoi M
    Panminerva Med; 2015 Sep; 57(3):121-5. PubMed ID: 25971329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supplementary management with Pycnogenol® in patients with lupus vasculitis in remission phases: a pilot, concept registry study.
    Cesarone MR; Belcaro G; Corsi M; Scipione C; Scipione V; Hu S; Hosoi M; Ledda A; Feragalli B; Cotellese R
    Minerva Cardioangiol; 2020 Apr; 68(2):146-152. PubMed ID: 32429631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xerostomia: prevention with Pycnogenol® supplementation: a pilot study.
    Belcaro G; Cesarone MR; Cornelli U; Scipione C; Scipione V; Dugall M; Hu S; Feragalli B; Hosoi M; Maione C; Cotellese R; Cesinaro Di Rocco P
    Minerva Stomatol; 2019 Dec; 68(6):303-307. PubMed ID: 32052619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pycnogenol® in postpartum symptomatic hemorrhoids.
    Belcaro G; Gizzi G; Pellegrini L; Dugall M; Luzzi R; Corsi M; Ippolito E; Ricci A; Cesarone MR; Ledda A; Bottari A; Errichi BM
    Minerva Ginecol; 2014 Feb; 66(1):77-84. PubMed ID: 24569406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression.
    Belcaro G; Ippolito E; Dugall M; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Steigerwalt RD; Cesarone MR; Pellegrini L; Luzzi R; Corsi M
    Int Angiol; 2015 Apr; 34(2):150-7. PubMed ID: 25519846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events.
    Belcaro G; Dugall M; Ippolito E; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Cesarone MR; Pellegrini L; Luzzi R; Corsi M; Feragalli B
    Minerva Cardioangiol; 2017 Feb; 65(1):24-31. PubMed ID: 26505327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central cardiovascular calcifications: supplementation with Pycnogenol® and Centellicum®: variations over 12 months.
    Hu S; Belcaro G; Cesarone MR; Feragalli B; Cotellese R; Dugall M; Scipione C; Scipione V; Maione C
    Minerva Cardioangiol; 2020 Feb; 68(1):22-26. PubMed ID: 31633315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention and control of jet lag symptoms and temporary impairment of cognitive function with Pycnogenol® in healthy individuals and in hypertensives.
    Belcaro G; Hu S; Hosoi M; Cesarone MR; Ledda A; Dugall M; Cornelli U; Saggino A; Cotellese R; Feragalli B; Cox D; Peterzan P; Scipione C; Scipione V
    Minerva Med; 2024 Apr; 115(2):178-184. PubMed ID: 38197571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of vaginal dryness in perimenopausal women. Supplementation with Lady Prelox®.
    Cesarone MR; Belcaro G; Scipione C; Scipione V; Dugall M; Hu S; Cotellese R; Feragalli B; Ledda A
    Minerva Ginecol; 2019 Dec; 71(6):434-441. PubMed ID: 32064827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pycnogenol may alleviate adverse effects in oncologic treatment.
    Belcaro G; Cesarone MR; Genovesi D; Ledda A; Vinciguerra G; Ricci A; Pellegrini L; Gizzi G; Ippolito E; Dugall M; Cacchio M; Di Renzo A; Stuard S
    Panminerva Med; 2008 Sep; 50(3):227-34. PubMed ID: 18927527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in symptoms and cochlear flow with pycnogenol in patients with Meniere's disease and tinnitus.
    Luzzi R; Belcaro G; Hu S; Dugall M; Hosoi M; Cacchio M; Ippolito E; Corsi M
    Minerva Med; 2014 Jun; 105(3):245-54. PubMed ID: 24988090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections.
    Cotellese R; Hu S; Cesarone MR; Belcaro G; Dugall M; Feragalli B; Hosoi M; Ippolito E; Corsi M; Luzzi R
    Panminerva Med; 2021 Sep; 63(3):343-348. PubMed ID: 34738775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pycnogenol® supplementation alleviates symptoms of Parkinson's disease with mild cognitive impairment.
    Belcaro G; Cesarone MR; Hu S; Hosoi M; Ledda A; Feragalli B; Saggino A; Cotellese R
    J Neurosurg Sci; 2022 Aug; 66(4):371-377. PubMed ID: 36153882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cramps and muscular pain: prevention with pycnogenol in normal subjects, venous patients, athletes, claudicants and in diabetic microangiopathy.
    Vinciguerra G; Belcaro G; Cesarone MR; Rohdewald P; Stuard S; Ricci A; Di Renzo A; Hosoi M; Dugall M; Ledda A; Cacchio M; Acerbi G; Fano F
    Angiology; 2006; 57(3):331-9. PubMed ID: 16703193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol®.
    Luzzi R; Belcaro G; Hosoi M; Feragalli B; Cornelli U; Dugall M; Ledda A
    Minerva Ginecol; 2017 Feb; 69(1):29-34. PubMed ID: 28116886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carotid plaque stabilization induced by the supplement association Pycnogenol® and centella asiatica (Centellicum®).
    Luzzi R; Belcaro G; Ippolito E
    Minerva Cardioangiol; 2016 Dec; 64(6):603-9. PubMed ID: 26496510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pycnogenol® improvements in asthma management.
    Belcaro G; Luzzi R; Cesinaro Di Rocco P; Cesarone MR; Dugall M; Feragalli B; Errichi BM; Ippolito E; Grossi MG; Hosoi M; Errichi S; Cornelli U; Ledda A; Gizzi G
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):57-64. PubMed ID: 22108478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid relief of signs/symptoms in chronic venous microangiopathy with pycnogenol: a prospective, controlled study.
    Cesarone MR; Belcaro G; Rohdewald P; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M
    Angiology; 2006; 57(5):569-76. PubMed ID: 17067979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benign prostatic hypertrophy: Pycnogenol® supplementation improves prostate symptoms and residual bladder volume.
    Ledda A; Belcaro G; Feragalli B; Cornelli U; Dugall M; Corsi M; Cesarone MR
    Minerva Med; 2018 Aug; 109(4):280-284. PubMed ID: 29947491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study.
    Errichi BM; Belcaro G; Hosoi M; Cesarone MR; Dugall M; Feragalli B; Bavera P; Hosoi M; Zulli C; Corsi M; Ledda A; Luzzi R; Ricci A
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):21-7. PubMed ID: 22108473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.